Unknown

Dataset Information

0

Two Hippo signaling modules orchestrate liver size and tumorigenesis


ABSTRACT: The Hippo pathway is a central regulator of organ size and tumorigenesis and is commonly depicted as a kinase cascade, with an increasing number of regulatory and adaptor proteins linked to its regulation over recent years. Here, we propose that two Hippo signaling modules, MST1/2-SAV1-WWC1-3 (HPO1) and MAP4K1-7-NF2 (HPO2), together regulate the activity of LATS1/2 kinases and YAP/TAZ transcriptional co-activators. In mouse livers, genetic inactivation of either HPO1 or HPO2 module results in partial activation of YAP/TAZ, bile duct hyperplasia, and hepatocellular carcinoma (HCC). On the other hand, inactivation of both HPO1 and HPO2 modules results in full activation of YAP/TAZ, rapid development of intrahepatic cholangiocarcinoma (iCCA), and early lethality. Interestingly, HPO1 has a predominant role in regulating organ size. HPO1 inactivation causes a homogenous YAP/TAZ activation and cell proliferation across whole liver, resulting in a proportional and rapid increase in liver size. Thus, this study has reconstructed the order of the Hippo signaling network and suggests that LATS1/2 and YAP/TAZ activities are finetuned by HPO1 and HPO2 modules to cause different cell fates, organ size changes, and tumorigenesis trajectories.

SUBMITTER: Prof. Fa-Xing Yu 

PROVIDER: S-SCDT-10_15252-EMBJ_2022112126 | biostudies-other |

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC2889558 | biostudies-literature
| S-EPMC5199712 | biostudies-literature
| S-EPMC5863541 | biostudies-literature
| S-EPMC6581792 | biostudies-literature
| S-EPMC7802350 | biostudies-literature
| S-EPMC7948509 | biostudies-literature
| S-EPMC3133743 | biostudies-literature
| S-EPMC7463967 | biostudies-literature
| S-EPMC5915420 | biostudies-literature
| S-EPMC3285349 | biostudies-literature